Navigation Links
Cedars-Sinai heart transplantation tip sheet
Date:4/24/2010

LOS ANGELES (April 21 2010) Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. The presentations will take place April 21 24 in Chicago during the 30th Annual Scientific Meeting of the International Society of Heart and Lung Transplantation.

"The International Society for Heart and Lung Transplantation Scientific Sessions bring together the world's experts in these fields which also includes basic science and mechanical circulatory assist devices," said Jon Kobashigawa, M.D., director of the Cedars-Sinai Heart Institute heart transplant program. "This important dialogue and exchange of valuable information will lead to improved survival and quality of life of our patients."

An associate director of the Cedars-Sinai Heart Institute, Kobashigawa is a past president of the International Society for Heart and Lung Transplantation. His research has resulted in groundbreaking medical protocols, such as customized anti-rejection medications for transplant patients.

Cedars-Sinai Heart Institute researchers will make more than 30 presentations during the meeting, including:

  • A review of 520 first-time heart transplant patients showed no significant difference survival rates based on age. Although patients 70 or older were more likely to have coronary artery disease and prior coronary bypass surgery, 10-year survival rates were equal to younger transplant patients. Older patients did have lower rates of diabetes mellitus, hypertension, obesity and smoking compared to the younger patients. Embargo lifts 8 a.m. CDT April 21.

  • Transplant patients who receive hearts from organ donors who were homeless are at increased risk for complications and poor outcomes. Although homelessness i
    '/>"/>

Contact: Sally Stewart
sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
2. Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms
3. Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting
4. Research team led by Cedars-Sinai identifies genes linked to ulcerative colitis
5. New strategies to improve treatment and avert heart failure in children
6. Added Sugars in Diet Threaten Heart Health
7. Blood test identifies people at risk for heart attack that other tests miss
8. Device Avoids Open-Heart Surgery When Artificial Valve Fails
9. Abnormal Heart Rhythm Linked to Alzheimers
10. HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart
11. B-vitamins Help Protect Against Stroke, Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... November 22, 2014 The topic of ... of block retaining walls. The article states that, “While they ... several necessary steps that go into creating this powerful look.” ... a retaining wall is choosing which kind of block matches ... , B&D Rockeries says, “The two main options are concrete ...
(Date:11/22/2014)... Recently, UWDress.com is gratified to introduce its ... In addition, the company has also offered an attracting ... leading online supplier of wedding dresses, UWDress.com is good ... best wedding guest gowns are provided over 20 colors, ... new selection is famous for high quality. Therefore, its ...
(Date:11/22/2014)... 2014 A new technology for ... which safely detects and identifies hazards inside and ... Developed by RHT SpectraSafe, the technology avoids hazardous ... in other areas including medical, recycling, military, and ... high frequency radio waves that pass harmlessly through ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 A Xarelto lawsuit ... woman who is seeking $10 million in damages from the ... . According to the lawsuit, the woman began using Xarelto ... woman alleges in her lawsuit she suffered life-threatening bleeding in ... personal injuries, pain, suffering and emotional distress. The lawsuit purports ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, 2014 ... treated in an ambulance by a neurologist equipped with a ... sooner patients get the clot dissolver -- tissue plasminogen activator ... researchers noted. For the best outcome, the drug needs to ... the researchers said. "The so-called ,golden hour, is associated ...
Breaking Medicine News(10 mins):Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
... Younis today announced a free webcast entitled, "BuzzMaking: Socializing Your Way ... executives in B2B companies facing challenging revenue goals and limited marketing ... ... Widely recognized B2B marketing expert Toby Younis today announced ...
... - Experts estimate that 20 percent of women ... time during their lives, particularly as they approach ... endometrial ablation (GEA) preserves the uterus, while decreasing ... an article published in the January issue of ...
... January 6, 2009 at 8:30 a.m. EST LEXINGTON, Mass., ... IDEV ) today announced that it has entered into ... Inc. will commence a tender offer to acquire 100 ... $370 million, or $4.50 per Indevus share, in cash ...
... Adds Marketed Products and Specialty Sales Force in ... Include Nine FDA-Approved TherapeuticsConference Call Scheduled for Today ... LEXINGTON, Mass., Jan. 5 Endo Pharmaceuticals (Nasdaq: ... (Nasdaq: IDEV ) announced today that ...
... FALLS, N.J., Jan. 5 CANTEL MEDICAL CORP. ... Segel, Senior Vice President-Corporate Development and Strategy, will be presenting ... The presentation is scheduled for 9:30 AM ET on Tuesday, ... New York City. The presentation will be available on the ...
... smokers to abandon their nascent efforts to kick the habit, ... , Brain scans taken during normal smoking activity and 24 ... a particular kind of brain activity when quitters see photographs ... in Psychopharmacology , sheds important light on why it,s ...
Cached Medicine News:Health News:B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking" 2Health News:Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding 2Health News:Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding 3Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 2Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 3Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 4Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 5Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 6Health News:Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals 7Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 2Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 3Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 4Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 5Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 6Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 7Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 8Health News:Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals 9Health News:New findings shed light on why smokers struggle to quit 2
(Date:11/21/2014)... Nov. 20, 2014 /CNW Telbec/ - KLOX Technologies Inc. ... following appointments: Todd Martensen ... newly created role of Chief Commercial Officer, to oversee ... topical photoconverter gel for the treatment of chronic and ... wounds, recently approved in Europe . ...
(Date:11/21/2014)... 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) announced ... of Anthony J. Cataldo as Chief Executive Officer, ... November 19, 2014, Ken Eaton resigned his positions ... Directors of Oxis International, Inc. to pursue new opportunities. ... Chief Executive Officer of Oxis International, Inc. Mr. Cataldo will ...
(Date:11/18/2014)... 2014 Respiratory Motion and IMI Co announced ... and services providers in Japan , ... innovative respiratory depression monitor, the ExSpiron™. As part of ... together to connect the clinical community in promoting patient ... bringing innovative medical devices and new technology to the ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... of Raydiance USP Laser Platform, to Separate Skin Layers ... ... Tissue Cleaning, Initial Proof of Concept Testing Successful ... Nov. 19 ,Raydiance, Inc. today announced that is has entered ...
... ... Europe, PARSIPPANY, N.J. and ... announced that the Committee for,Medicinal Products for Human Use (CHMP) of the ... Angiox(R),(bivalirudin) to adult patients with acute coronary syndromes (ACS) planned,for urgent or ...
Cached Medicine Technology:Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches 2Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches 3Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches 4CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes 2CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes 3CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes 4CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes 5
For the quantitative in vitro determination of Inorganic Phosphorous in serum....
The TBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of total bilirubin in serum and plasma...
The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate dehydrogenase activity in serum or plasma...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Medicine Products: